参考文献
［1］Shimazaki Y，Blackstone EH，Kirklin JW.The natural history of isolated congenital pulmonary valve incompetence：surgical implications［J］.Thorac Cardiovasc Surg，1984，32：257-259.
［2］McElhinney DB，Hennesen JT.The Melody valve and Ensemble delivery system for transcatheter pulmonary valve replacement［J］.Ann N Y Acad Sci，2013，1291：77-85.
［3］Murphy JG，Gersh BJ，Mair DD，et al.Long-term outcome in patients undergoing surgical repair of tetralogy of Fallot［J］.N Engl J Med，1993，329：593-599.
［4］Warnes CA，Williams RG，Bashore TM，et al.ACC/AHA 2008 guidelines for the management of adults with congenital heart disease：a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines［J］.J Am Coll Cardiol，2008，52：e 143-263.
［5］d'Udekem Y，Ovaert C，Grandjean F，et al.Tetralogy of Fallot：transannular and right ventricular patching equally affect late functional status［J］.Circulation，2000，102（19 Suppl 3）：Ⅲ116-Ⅲ122.
［6］de Ruijter FT，Weenink I，Hitchcock FJ，et al.Right ventricular dysfunction and pulmonary valve replacement after correction of tetralogy of Fallot［J］.Ann Thorac Surg，2002，73（6）：1794-1800.
［7］Labombarda F，Hamilton R，Shohoudi A，et al.Increasing prevalence of atrial fibrillation and permanent atrial arrhythmias in congenital heart disease［J］.J Am Coll Cardiol，2017，70：857-865.
［8］惠慰，孙斌，黄国英，等，超声心动图评估法洛四联症术后中远期疗效109 例随访［J］.中国超声医学杂志，2001（4）：33-35.
［9］姜睿，闫军，李守军，等，法洛四联症根治术178 例临床分析［J］.临床心血管病杂志，2011（9）：702-704.
［10］纪广玉，徐志云，王志农，等，成人法洛四联症外科治疗的远期疗效［J］.中国胸心血管外科临床杂志，2010（4）：287-291.
［11］谢兆丰，张智伟，徐衍梅，等.法洛四联症术后远期疗效及并发症［J］.临床心血管病杂志，2013，29（8）：618-620.
［12］龙愉良，潘文志，詹智，等.法洛四联症外科根治术后患者的肺动脉瓣功能分析［J］.中华心血管病杂志，2017，45（8）：722-725.
［13］Chaturvedi RR，Redington AN.Pulmonary regurgitation in congenital heart disease［J］.Heart，2007，93：880-889.
［14］Nollert GD，Däbritz SH，Schmoeckel M，et al.Risk factors for sudden death after repair of tetralogy of Fallot［J］.Ann Thorac Surg，2003，76：1901-1905.
［15］Gatzoulis MA，Balaji S，Webber SA，et al.Risk factors for arrhythmia and sudden cardiac death late after repair of tetralogy of Fallot：a multicentre study［J］.Lancet，2000，356：975-981.
［16］Harrison DA，Harris L，Siu SC，et al.Sustained ventricular tachycardia in adult patients late after repair of tetralogy of Fallot［J］.J A m C oll C ardi ol，1997，30：1368-1373.
［17］Gatzoulis MA，Till JA，Somerville J，et al.Mechanoelectrical interaction in tetralogy of Fallot.QRS prolongation relates to right ventricular size and predicts malignant ventricular arrhythmias and sudden death［J］.Circulation，1995，92：231-237.
［18］Ferraz Cavalcanti PE，Sá MP，Santos CA，et al.Pulmonary valve replacement after operative repair of tetralogy of Fallot：metaanalysis and meta-regression of 3，118 patients from 48 studies［J］.Journal of the American College of Cardiology，2013，62（23）：2227-2243.
［19］Therrien J，Provost Y，Merchant N，et al.Optimal timing for pulmonary valve replacement in adults after tetralogy of Fallot repair［J］.Am J Cardiol，2005，95：779-782.(https://www.daowen.com)
［20］Oosterhof T，van Straten A，Vliegen HW，et al.Preoperative thresholds for pulmonary valve replacement in patients with corrected tetralogy of Fallot using cardiovascular magnetic resonance［J］.Circulation，2007，116：545-551.
［21］Geva T，Gauvreau K，Powell AJ，et al.Randomized trial of pulmonary valve replacement with and without right ventricular remodeling surgery［J］.Circulation，2010，122（11 Suppl）：S201-208.
［22］Lee C，Kim YM，Lee CH，et al.Outcomes of pulmonary valve replacement in 170 patients with chronic pulmonary regurgitation after relief of right ventricular outflow tract obstruction：implications for optimal timing of pulmonary valve replacement［J］.J Am Coll Cardiol，2012，60：1005-1014.
［23］Geva T. Repaired tetralogy of Fallot：the roles of cardiovascular magnetic resonance in evaluating pathophysiology and for pulmonary valve replacement decision support［J］.J Cardiovasc Magn Reson，2011，13：9.
［24］Dave HH，Buechel ER，Dodge-Khatami A，et al.Early insertion of a pulmonary valve for chronic regurgitation helps restoration of ventricular dimensions［J］.Ann Thorac Surg，2005，80：1615-1620.
［25］Frigiola A，Tsang V，Bull C，et al.Biventricular response after pulmonary valve replacement for right ventricular outflow tract dysfunction：is age a predictor of outcome？［J］.Circulation，2008，118（14 Suppl）：S182-S190.
［26］Warnes CA，Williams RG，Bashore TM，et al.ACC/AHA 2008 guidelines for the management of adults with congenital heart disease：executive summary：a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines（writing committee to develop guidelines for the management of adults with congenital heart disease）［J］.Circulation，2008，118：2395-2451.
［27］Amsterdam EA，Wenger NK，Brindis RG，et al.2014 AHA/ACC Guideline for the Management of Patients With Non-STElevation Acute Coronary Syndromes A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines［J］.Journal of the American College of Cardiology，2014，64（24）：2645-2687.
［28］Baumgartner H，Bonhoeffer P，De Groot NM，et al.ESC guidelines for the management of grown-up congenital heart disease［J］.E ur H eart J，2010，31：2915-2957.
［29］Hijazi ZM，Ruiz CE，Zahn E，et al.SCAI/AATS/ACC/STS Operator and Institutional Requirements for Transcatheter Valve Repair and Replacement，Part Ⅲ：Pulmonic Valve［J］.J Am Coll Cardiol，2015，65（23）：2556-2563.
［30］Müller J，Engelhardt A，Fratz S，et al.Improved exercise performance and quality of life after percutaneous pulmonary valve implantation［J］.Int J Cardio1，2014，173（3）：388-392.
［31］Ansari MM，Cardoso R，Garcia D，et al.Percutaneous Pulmonary Valve Implantation：Present Status and Evolving Future［J］.Journal of the American College of Cardiology，2015，66（20）：2246-2255.
［32］万俊义，陆敏杰，张戈军，等.经皮肺动脉瓣植入术后患者心功能的变化8 例分析［J］.中国循环杂志，2016，31（7）：683-686.
［33］Cheatham JP，Hellenbrand WE，Zahn EM，et al.Clinical and hemodynamic outcomes up to 7 years after transcatheter pulmo-nary valve replacement in the US melody valve investigational device exemption trial［J］.Circulation，2015，131（22）：1960-1970.
［34］Virk SA，Liou K，Chandrakumar D，et al. Percutaneous pulm-onary valve implantation：A systematic review of clinical outc-omes［J］.Int J Cardiol，2015，201：487-489.
［35］龙愉良，潘文志，管丽华，等.经皮自膨胀式肺动脉瓣植入术的长期随访［J］.复旦学报（医学版），2018（3）：336-340.
［36］Zhou D，Pan W，Jilaihawi H，et al.A self-expanding percutaneous valve for patients with pulmonary regurgitation and an enlarged native right ventricular outflow tract：one-year results［J］.EuroIntervention，2018：EIJ-D-18-00715.
［37］Morgan G，Prachasilchai P，Promphan W，et al.Medium-Term Results of Percutaneous Pulmonary Valve Implantation using The Venus P-valveTM：international experience［J］.EuroIntervention，2018：EIJ-D-18-00299.
［38］中华医学会心血管病学分会结构性心脏病学组.经皮肺动脉瓣置入术中国专家建议［J］.中国医学前沿杂志：电子版，2016，24（10）：20-24.